351 related articles for article (PubMed ID: 3105323)
1. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
Johnson TL; Lloyd RV; Thor A
Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
[TBL] [Abstract][Full Text] [Related]
2. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
[TBL] [Abstract][Full Text] [Related]
4. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
Gui K
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
6. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
[TBL] [Abstract][Full Text] [Related]
9. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.
Lloyd RV; Johnson TL; Blaivas M; Sisson JC; Wilson BS
Am J Pathol; 1985 Jul; 120(1):106-11. PubMed ID: 3893150
[TBL] [Abstract][Full Text] [Related]
10. CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid.
Aydin O; Yildiz L; Kefeli M; Kandemir B
Pathol Res Pract; 2008; 204(6):359-65. PubMed ID: 18337018
[TBL] [Abstract][Full Text] [Related]
11. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
12. Presence of endothelin-1 in the normal and pathological human thyroid.
Lenziardi M; Viacava P; Fiorini I; Castagna M; Nardini V; Pollina L; De Negri F; Goletti O; Di Coscio G; Bevilacqua G
J Endocrinol Invest; 1995 May; 18(5):336-40. PubMed ID: 7594220
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry of thyroid hormones as a functional parameter in thyroid pathology.
Taşcă C; Stefăneanu L; Simionescu L; Medeşan C
Morphol Embryol (Bucur); 1985; 31(4):261-8. PubMed ID: 2934622
[TBL] [Abstract][Full Text] [Related]
14. Transformation of thyroid epithelium is associated with loss of c-kit receptor.
Natali PG; Berlingieri MT; Nicotra MR; Fusco A; Santoro E; Bigotti A; Vecchio G
Cancer Res; 1995 Apr; 55(8):1787-91. PubMed ID: 7536131
[TBL] [Abstract][Full Text] [Related]
15. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
[TBL] [Abstract][Full Text] [Related]
16. Patterns of basement membrane laminin distribution in nonneoplastic and neoplastic thyroid tissue.
Campo E; Perez M; Charonis AA; Axiotis CA; Merino MJ
Mod Pathol; 1992 Sep; 5(5):540-6. PubMed ID: 1344818
[TBL] [Abstract][Full Text] [Related]
17. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical demonstration of thyroglobulin in thyroid pathology.
Stefăneanu L; Simionescu L; Aman E; Taşcă C
Endocrinologie; 1984; 22(1):55-9. PubMed ID: 6369503
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
20. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
